When Indigenous Knowledge Meets Commercialisation: Lessons from the Hoodia Case

South Africa possesses one of the richest reservoirs of Indigenous Knowledge Systems (IKS) in the world. Across generations, communities have developed deep understandings of medicinal plants, natural products, agriculture, food systems, and health practices that remain highly relevant in modern biotechnology, pharmaceuticals, nutraceuticals, and cosmetics. Yet one critical question continues to shape the future of Indigenous Knowledge-based product development:

How do we commercialise indigenous knowledge ethically, sustainably, and inclusively?

One of the most important case studies in Indigenous Knowledge commercialisation is the story of Hoodia gordonii, a plant indigenous to the Kalahari Desert traditionally used by the San people to suppress hunger and thirst during long hunting expeditions. While the story is frequently discussed in the context of bioprospecting and intellectual property, its lessons extend far beyond ethics alone. For deep-tech entrepreneurs, researchers, universities, technology transfer offices, and policymakers, it offers critical insights into innovation commercialisation, benefit-sharing, regulatory strategy, and the realities of translating Indigenous Knowledge into market-ready products.

From Indigenous Knowledge to Global Commercial Interest

For generations, the San community relied on Hoodia gordonii as part of their traditional survival practices, with knowledge passed down orally through communities over centuries. In the 1990s, scientific research conducted by a national research institute isolated an active compound believed to be responsible for appetite suppression, resulting in patent protection and substantial international commercial interest in obesity and weight management applications.

What followed appeared, initially, to be a promising pathway for biotechnology commercialisation. International licensing agreements were secured, and major multinational companies became involved in product development. The commercial opportunity seemed significant, particularly given growing global interest in natural appetite suppressants and functional health products.

However, a critical issue quickly emerged.

The traditional knowledge holders had not initially been consulted, informed, or included in the commercialisation process. This triggered widespread criticism and raised concerns around biopiracy, ethical commercialisation, and the protection of Indigenous Knowledge Systems.

Following advocacy and public pressure, a formal benefit-sharing agreement was negotiated with the San community, providing for participation in future royalties and milestone payments tied to commercial success.

At face value, this appeared to represent a positive outcome.

Yet the commercial reality proved far more complex.

Why Strong Science and Patents Were Not Enough

Despite significant commercial interest and formal agreements, Hoodia-based product development ultimately struggled to achieve long-term success.

Several major commercial partners eventually abandoned development efforts due to concerns surrounding efficacy, safety, regulatory requirements, and uncertain market viability. At the same time, unregulated Hoodia products entered international markets, diluting the value of the original research and creating confusion around product quality, legitimacy, and consumer trust.

The outcome offers an important lesson frequently overlooked in biotechnology and natural product commercialisation:

Scientific discovery and intellectual property protection do not automatically translate into successful commercial outcomes.

Commercialisation requires alignment between multiple factors, including:

• robust scientific validation,

• regulatory feasibility,

• manufacturing readiness,

• market demand,

• sustainable supply chains,

• and credible market positioning.

  
  

Without this alignment, even highly promising technologies may struggle to deliver meaningful impact.

  The Limits of Intellectual Property in Indigenous Knowledge Commercialisation

The Hoodia case also exposed important limitations within traditional intellectual property systems.

Conventional patent frameworks are generally designed to protect individual inventions and clearly defined ownership structures. Indigenous Knowledge, however, is often collective, orally transmitted, intergenerational, and deeply embedded within communities and cultural Importantly, the Hoodia experience became a catalyst for substantial policy and legislative reform in South Africa. Since then, the intellectual property and biodiversity governance landscape has evolved considerably through the introduction of the Indigenous Knowledge Systems (IKS) Act, strengthened provisions under the National Environmental Management: Biodiversity Act (NEMBA), and the implementation of Access and Benefit-Sharing (ABS) Regulations.

These frameworks now place far greater emphasis on prior informed consent, equitable benefit sharing, legal recognition of Indigenous Knowledge holders, and formal permitting processes linked to the use of indigenous biological resources and associated traditional knowledge. They also provide clearer mechanisms for monitoring, compliance, and accountability throughout the commercialisation journey.

The key lesson from Hoodia is therefore not only one of caution, but also of progress. It highlighted the critical importance of early and meaningful community engagement, transparent legal arrangements, capacity building for knowledge holders, and sustained oversight of commercialisation outcomes. Today, innovators and researchers operate within a far more structured and ethically grounded environment designed to ensure that Indigenous Knowledge-based innovation delivers fairer, more inclusive benefits.

The Hoodia experience demonstrated that legal agreements alone are insufficient. Even when benefit-sharing frameworks exist, meaningful outcomes depend on whether a commercially viable product ultimately reaches the market. Without successful commercialisation and effective monitoring mechanisms, communities may receive limited practical benefit.

This reinforces the importance of building stronger frameworks for ethical innovation that go beyond compliance and actively empower communities throughout the commercialisation process.

What Researchers and Innovators Can Learn

For researchers, universities, entrepreneurs, and innovation agencies seeking to commercialise Indigenous Knowledge-based products, the Hoodia case offers several critical lessons.

Community engagement cannot happen late in the process. It must begin early, before intellectual property decisions are made, and should be based on trust, transparency, and prior informed consent.

Commercialisation strategies must also extend beyond patents. Innovators need to evaluate market readiness, regulatory pathways, sustainable sourcing, manufacturing scalability, and long-term business models from the outset.

Equally important is ensuring that benefit-sharing agreements are practical, transparent, and supported by ongoing governance and monitoring mechanisms. Community participation should not be symbolic. It should form part of a genuine innovation partnership.

Finally, expectations around commercial success must remain realistic. Not every promising Indigenous Knowledge-based product will become commercially viable. This makes robust feasibility assessment and techno-economic analysis essential during early-stage development.

Building a More Inclusive Future for Indigenous Knowledge Commercialisation

At Maravion, we believe Indigenous Knowledge Systems represent one of Africa’s greatest untapped innovation opportunities. However, unlocking this potential requires an approach that combines scientific validation, ethical commercialisation, regulatory understanding, and inclusive value creation.

Through our work in Indigenous Knowledge commercialisation, biotech strategy, techno-economic analysis, and innovation ecosystem development, we support researchers, universities, communities, and entrepreneurs in translating knowledge into credible, commercially viable opportunities while preserving cultural integrity and promoting equitable participation.

The Hoodia story reminds us that successful commercialisation is not simply about patents or products.

The Hoodia story reminds us that successful commercialisation is not simply about patents or products.

It is about building systems of innovation that are ethical, commercially realistic, scientifically robust, and genuinely inclusive.

It is about building systems of innovation that are ethical, commercially realistic, scientifically robust, and genuinely inclusive.